Correction to: Safety and effectiveness of Evicel® fibrin sealant as an adjunct to sutured dural repair in children undergoing cranial neurosurgery

Correction to: Child’s Nervous System

https://doi.org/10.1007/s00381-024-06434-4

In Tables 1, 2, 3, 4, 5, 6 of this article, there are sub-entries that requires indentions for readers clarity. Below are the updated tables.

Table 1 Patient Characteristics (ITT Set). Medical history shows disorders that occurred in ≥10% of subjects.

Table 2 Procedural Characteristics (ITT Set).

Table 3 Treatment Parameters and Intra-operative Outcomes (Safety Set).

Table 4 Primary Efficacy Analysis and Sensitivity Analyses. Success was defined as the achievement of intra-operative watertight closure after completion of the randomized treatment, as assessed by provocative testing with Valsalva maneuver.

Table 5 Adverse Events and Relatedness to Study Product (Determined for Evicel® Group Only) and Procedure (Safety Set).

Table 6 Surgical Site Complications Observed within 30 Days Postoperatively (Safety Set). All complications are also reported as AEs (Table 5).

The original article has been corrected.